DHFR and toxoplasmosis: Treatment of toxoplasmosis usually uses a combination of a sulfamide with pyrimethamine, which has a remarkable synergistic activity against the replicating form of T. gondii, through the sequential inhibition of parasite dihydropteroate synthase (DHPS) and dihydrofolate reductase (DHFR).